Literature DB >> 12798014

A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania.

Achim G Schneider1, Zulfikar Premji, Ingrid Felger, Tom Smith, Salim Abdulla, Hans-Peter Beck, Hassan Mshinda.   

Abstract

This study was undertaken to validate the relevance of Chloroquine (CQ) resistance markers pfcrt(76) and pfmdr1(86) in an endemic area in Tanzania. After treatment with CQ, recrudescence was distinguished from new infection by msp2 genotyping, and the number of concurrent infections was also determined. The rate of children with recrudescent parasites at day 7 and/or day 14 amounted to a parasitological failure rate of 22.4% using PCR. The mean multiplicity of infection at day 0 was 3.2 (n=71). The allelic frequencies of the mutated pfcrt(76) and pfmdr1(86) were estimated to be 92 and 77%, respectively. Both values exceeded by far the observed frequency of 14% of recrudescent parasites as calculated on the whole analysed parasite population taking multiple infections into account. Although neither mutant allele is of predictive value for parasitological resistance, there is evidence for a role of pfcrt(76) in CQ resistance in the natural parasite population. All wild-type pfcrt(76) alleles were eliminated before day 3, after the onset of CQ treatment and no recrudescent parasite with the wild-type allele was observed at later time points. The discrepancy between the rate of resistant parasites (14%) and the frequency of the mutant pfcrt(76) allele (92%), however, indicates that other polymorphisms and other factors must be involved in CQ resistance. No selective elimination of the pfmdr1(86) wild-type allele was observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12798014     DOI: 10.1016/s1567-1348(01)00021-1

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  18 in total

1.  Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.

Authors:  Thomas T Thomsen; Deus S Ishengoma; Bruno P Mmbando; John P Lusingu; Lasse S Vestergaard; Thor G Theander; Martha M Lemnge; Ib C Bygbjerg; Michael Alifrangis
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.

Authors:  Sankar Sridaran; Betzabe Rodriguez; Aida Mercedes Soto; Alexandre Macedo De Oliveira; Venkatachalam Udhayakumar
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

3.  A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.

Authors:  Viswanathan Lakshmanan; Patrick G Bray; Dominik Verdier-Pinard; David J Johnson; Paul Horrocks; Rebecca A Muhle; George E Alakpa; Ruth H Hughes; Steve A Ward; Donald J Krogstad; Amar Bir Singh Sidhu; David A Fidock
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

4.  In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal.

Authors:  Ousmane Sarr; Alissa Myrick; Johanna Daily; Bernard M Diop; Therese Dieng; Omar Ndir; Pape Salif Sow; Souleymane Mboup; Dyann F Wirth
Journal:  Parasitol Res       Date:  2005-06-29       Impact factor: 2.289

5.  Bias-corrected maximum-likelihood estimation of multiplicity of infection and lineage frequencies.

Authors:  Meraj Hashemi; Kristan A Schneider
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

6.  Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.

Authors:  Allen L Malisa; Richard J Pearce; Salim Abdulla; Hassan Mshinda; Patrick S Kachur; Peter Bloland; Cally Roper
Journal:  Malar J       Date:  2010-07-05       Impact factor: 2.979

7.  Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.

Authors:  Mariangela Bonizzoni; Yaw Afrane; Frederick N Baliraine; Dolphine A Amenya; Andrew K Githeko; Guiyun Yan
Journal:  Infect Genet Evol       Date:  2009-05-04       Impact factor: 3.342

8.  Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data.

Authors:  Anne E P Frosch; Meera Venkatesan; Miriam K Laufer
Journal:  Malar J       Date:  2011-05-09       Impact factor: 2.979

9.  Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.

Authors:  Jutta Marfurt; Thomas A Smith; Ian M Hastings; Ivo Müller; Albert Sie; Olive Oa; Moses Baisor; John C Reeder; Hans-Peter Beck; Blaise Genton
Journal:  Malar J       Date:  2010-01-07       Impact factor: 2.979

Review 10.  A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.

Authors:  Stéphane Picot; Piero Olliaro; Frédérique de Monbrison; Anne-Lise Bienvenu; Ric N Price; Pascal Ringwald
Journal:  Malar J       Date:  2009-05-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.